Artículos por temáticas

Playing Around the Coumarin Core in the Discovery of Multimodal Compounds Directed at Alzheimer's-Related Targets: A Recent Literature Overview

Rullo M, La Spada G, Stefanachi A, Macchia E, Pisani L, Leonetti F.

Molecules. 2025 Feb 14;30(4):891. doi: 10.3390/molecules30040891.

Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research

Smith EE, Phillips NA, Feldman HH, Borrie M, Ganesh A, Henri-Bhargava A, Desmarais P, Frank A, Badhwar A, Barlow L, Bartha R, Best S, Bethell J, Bhangu J, Black SE, Bocti C, Bronskill SE, Burhan AM, C

J Prev Alzheimers Dis. 2025 Mar;12(3):100068. doi: 10.1016/j.tjpad.2025.100068. Epub 2025 Jan 31.

Examining the role of antioxidant supplementation in mitigating oxidative stress markers in Alzheimer's disease: a comprehensive review

Jawad M, Uthirapathy S, Altalbawy FMA, Oghenemaro EF, Rizaev J, Lal M, Eldesoqui M, Sharma N, Pramanik A, Al-Hamairy AK.

Inflammopharmacology. 2025 Feb;33(2):573-592. doi: 10.1007/s10787-024-01622-9. Epub 2024 Dec 19.

Improvements in Exercise for Alzheimer's Disease: Highlighting FGF21-Induced Cerebrovascular Protection

Wang J, Meng X, Yang J, Tang Y, Zeng F, Wang Y, Chen Z, Chen D, Zou R, Liu W.

Neurochem Res. 2025 Feb 4;50(2):95. doi: 10.1007/s11064-025-04350-w.

Advances in the structural modification of Alzheimer's disease drug - Huperzine A

Zhu X, Xu JB, Gao F, Wan LX.

Bioorg Chem. 2025 Jan;154:108012. doi: 10.1016/j.bioorg.2024.108012. Epub 2024 Nov 29.

The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence

Aisen P, Bateman RJ, Crowther D, Cummings J, Dwyer J, Iwatsubo T, Kosco-Vilbois M, McDade E, Mohs R, Scheltens P, Sperling R, Selkoe D.

Alzheimers Dement. 2025 Jan;21(1):e14342. doi: 10.1002/alz.14342. Epub 2024 Nov 13.

Different physical exercise in the treatment of Alzheimer's disease

Deng T, Yu W, Lü Y.

Psychogeriatrics. 2025 Jan;25(1):e13207. doi: 10.1111/psyg.13207. Epub 2024 Oct 26.

Post-Hoc Assessment of Cognitive Efficacy in Alzheimer's Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial

Ayasse ND, Stewart WF, Lipton RB, Gomez-Ulloa D, Runken MC.

Curr Alzheimer Res. 2025;21(5):353-365. doi: 10.2174/0115672050316936240905064215.

Twelve weeks of exercise training improves cognitive status, physical performance and quality of life in Alzheimer's disease: A systematic review and meta-analysis

de Sá Leitão CVF, Moraes BF, Leite GAPD, Duarte AG, da Silva MVG, de Oliveira GM, Andrade FAB, da Silva JAB, Dos Santos RCC, Figueiredo GS, Campos HO, Leite LHR, Drummond LR, Coimbra CC.

Ageing Res Rev. 2025 Feb;104:102655. doi: 10.1016/j.arr.2025.102655. Epub 2025 Jan 10.

Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease

Lee E, Chang Y.

Cells. 2025 Jan 22;14(3):168. doi: 10.3390/cells14030168.

Association of dipeptidyl peptidase-4 with Alzheimer's disease: A new therapeutic prospect

Wang X, Chen L, Li W, He Z, Jiang H.

J Alzheimers Dis. 2025 Jan;103(2):319-332. doi: 10.1177/13872877241304673. Epub 2025 Jan 8.

Therapeutic Potential of Polyphenols in Cellular Reversal of Patho-Mechanisms of Alzheimer's Disease Using In Vitro and In Vivo Models: A Comprehensive Review

Samal M, Srivastava V, Khan M, Insaf A, Penumallu NR, Alam A, Parveen B, Ansari SH, Ahmad S.

Phytother Res. 2025 Jan;39(1):25-50. doi: 10.1002/ptr.8344. Epub 2024 Nov 4.

High definition transcranial direct current stimulation as an intervention for cognitive deficits in Alzheimer's dementia: A randomized controlled trial

LoBue C, Chiang HS, Salter A, McClintock S, Nguyen TP, Logan R, Smernoff E, Pandya S, Hart J.

J Prev Alzheimers Dis. 2025 Feb;12(2):100023. doi: 10.1016/j.tjpad.2024.100023. Epub 2025 Jan 1.

Molecular Mechanisms of Alzheimer's Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy

Ahn EH, Park JB.

Cells. 2025 Jan 10;14(2):89. doi: 10.3390/cells14020089.

The effects of transcranial direct current stimulation on global cognition in patients with Alzheimer's disease: An update meta-analysis

Su S, Huang R, Liu Y.

J Alzheimers Dis. 2025 Jan;103(1):19-37. doi: 10.1177/13872877241298303. Epub 2025 Jan 9.